Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-171.59M
↓ 98% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-86.47M
Historical baseline
PeriodValueYoY Change
TTM$-171.59M-20.3%
2024$-142.60M-128.5%
2023$-62.41M-112.4%
2022$-29.38M-11.5%
2021$-26.35M-